About Magnitude Biosciences
Magnitude Biosciences is a company based in Durham (United Kingdom) founded in 2018. Magnitude Biosciences has raised $1.95 million across 6 funding rounds from investors including Maven Capital Partners, UK Research and Innovation and European Union. The company has 12 employees as of February 28, 2022. Magnitude Biosciences offers products and services including C. elegans Assays and WormGazer™ Technology. Magnitude Biosciences operates in a competitive market with competitors including Slingshot Bioscience, StemoniX, InterAx Biotech, ZoBio and Signal Pharmaceuticals, among others.
- Headquarter Durham, United Kingdom
- Employees 12 as on 28 Feb, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Magnitude Biosciences Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.95 M (USD)
in 6 rounds
-
Latest Funding Round
$943.59 K (USD), Seed
May 27, 2025
-
Investors
Maven Capital Partners
& 4 more
-
Employee Count
12
as on Feb 28, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Magnitude Biosciences
Magnitude Biosciences offers a comprehensive portfolio of products and services, including C. elegans Assays and WormGazer™ Technology.
Customized studies for drug efficacy and toxicity testing
Tool for monitoring worm mobility in biological research
People of Magnitude Biosciences
Unlock access to complete
Unlock access to complete
Funding Insights of Magnitude Biosciences
Magnitude Biosciences has successfully raised a total of $1.95M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $943.59 thousand completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Magnitude Biosciences
Magnitude Biosciences has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Maven Capital Partners, UK Research and Innovation and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in UK companies across diverse sectors.
|
Locked | Locked | Locked | |
|
Multiple sectors are targeted for private equity investments.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Magnitude Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Magnitude Biosciences
Investment portfolio details for Magnitude Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Magnitude Biosciences
Detailed financials for Magnitude Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Magnitude Biosciences Comparisons
Peer comparison for Magnitude Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Magnitude Biosciences
Magnitude Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Slingshot Bioscience, StemoniX, InterAx Biotech, ZoBio and Signal Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Next-generation synthetic cells are developed for diagnostics and therapeutics.
|
|
| Locked | Locked | Locked |
Developing a commercial scale printer for the high-volume growth and differentiation of stem cells and stem cell products.
|
|
| Locked | Locked | Locked |
Mutated arrestins are employed as biosensors for GPCR drug discovery.
|
|
| Locked | Locked | Locked |
Provider of fragment-based drug discovery services
|
|
| Locked | Locked | Locked |
Small molecule drugs regulating disease-associated genes are developed.
|
Detailed competitors of Magnitude Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Magnitude Biosciences
Complete news archive for Magnitude Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Magnitude Biosciences
Magnitude Biosciences was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Magnitude Biosciences is headquartered in Durham, United Kingdom.
Magnitude Biosciences is a funded company, having raised a total of $1.95M across 6 funding rounds to date.
As of Feb 28, 2022, the latest employee count at Magnitude Biosciences is 12.
Magnitude Biosciences was established in 2018 in Durham, United Kingdom, within the biotechnology sector. Cell-free in vitro assays based on C. elegans models are delivered to support drug discovery efforts. Operations encompass prescreening of compounds to mitigate risks in mammalian studies, along with screening of mutant libraries and compound collections for targeted evaluations.
Magnitude Biosciences's top competitors include Slingshot Bioscience, StemoniX and Sequence Bio.
Magnitude Biosciences offers C. elegans Assays and WormGazer™ Technology.
Magnitude Biosciences has 5 investors. Key investors include Maven Capital Partners, UK Research and Innovation, European Union, Saker Capital, and Northstar Ventures.